Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-08-17 5:28 pm Purchase | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Peak Asia Investment Holdings V Ltd | 27,665,768 26.000% | 12,088,808 (+77.61%) | View |
2023-08-17 11:54 am Sale | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) | 57,815,846 36.600% | -51,696,532 (-47.21%) | View |
2023-02-24 06:06 am Purchase | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) | 109,512,378 83.900% | 36,573,434 (+50.14%) | View |
2022-07-29 2:46 pm Unchanged | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Peak Asia Investment Holdings V Ltd | 15,576,960 16.900% | 0 (Unchanged) | View |
2022-07-29 08:09 am Purchase | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Hainan Oriental Jiechuang Investment Partnership (Limited Partnership) | 72,938,944 79.200% | 72,938,944 (New Position) | View |
2022-07-29 06:15 am Sale | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Zhou Pengwu | 20,458,016 22.200% | -1,779,728 (-8.00%) | View |
2022-07-29 06:10 am Unchanged | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Ding Wenting | 15,490,692 16.800% | 0 (Unchanged) | View |
2022-07-14 07:30 am Unchanged | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Hainan Runming Biotechnology Co. Ltd. | 21,413,276 23.250% | 0 (Unchanged) | View |
2022-06-10 06:00 am Purchase | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Hainan Runming Biotechnology Co. Ltd. | 21,413,276 23.250% | 21,413,276 (New Position) | View |
2022-02-28 08:38 am Sale | 13G | AESTHETIC MED INTL HLDGS GROUP PAIYY | IDG-Accel China Growth Fund III L.P. | 2,376,522 3.400% | -3,623,478 (-60.39%) | View |
2022-02-28 08:30 am Purchase | 13G | AESTHETIC MED INTL HLDGS GROUP PAIYY | IDG-Accel China Growth Fund III L.P. | 6,000,000 8.500% | 6,000,000 (New Position) | View |
2021-05-24 4:03 pm Sale | 13G | AESTHETIC MED INTL HLDGS GROUP PAIYY | Zhou Pengwu | 22,237,744 31.400% | -3,046,390 (-12.05%) | View |
2020-09-22 12:28 pm Unchanged | 13D | AESTHETIC MED INTL HLDGS GROUP PAIYY | Peak Asia Investment Holdings V Ltd | 15,576,960 22.000% | 0 (Unchanged) | View |
2020-04-21 09:31 am Purchase | 13G | AESTHETIC MED INTL HLDGS GROUP PAIYY | Peak Asia Investment Holdings V Ltd | 15,576,960 22.000% | 15,576,960 (New Position) | View |
2020-03-04 06:09 am Purchase | 13G | AESTHETIC MED INTL HLDGS GROUP PAIYY | Ding Wenting | 15,490,692 21.900% | 15,490,692 (New Position) | View |
2020-03-04 06:06 am Purchase | 13G | AESTHETIC MED INTL HLDGS GROUP PAIYY | Zhou Pengwu | 25,284,134 35.700% | 25,284,134 (New Position) | View |